I‐Wu Chen

1.6k total citations
22 papers, 818 citations indexed

About

I‐Wu Chen is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, I‐Wu Chen has authored 22 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Infectious Diseases and 8 papers in Molecular Biology. Recurrent topics in I‐Wu Chen's work include HIV/AIDS drug development and treatment (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV Research and Treatment (4 papers). I‐Wu Chen is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and HIV Research and Treatment (4 papers). I‐Wu Chen collaborates with scholars based in United States and Japan. I‐Wu Chen's co-authors include Jiunn H. Lin, Masato Chiba, F A deLuna, Masayo Yamazaki, Jerome Hochman, William Neway, Tomoyuki Ohe, Janice Rowe, Joy A. Nishime and Joseph P. Vacca and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

I‐Wu Chen

22 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I‐Wu Chen United States 16 338 301 193 169 121 22 818
Barbara A. Domin United States 20 201 0.6× 501 1.7× 88 0.5× 67 0.4× 193 1.6× 31 1.1k
Nicola F. Smith United States 16 605 1.8× 618 2.1× 82 0.4× 222 1.3× 243 2.0× 22 1.3k
Grace Chan United States 14 444 1.3× 114 0.4× 113 0.6× 250 1.5× 194 1.6× 18 720
Karen May Germany 14 478 1.4× 176 0.6× 37 0.2× 145 0.9× 57 0.5× 25 921
Kari Vastag United States 10 102 0.3× 146 0.5× 116 0.6× 36 0.2× 88 0.7× 14 477
Keith Riccardi United States 17 276 0.8× 349 1.2× 225 1.2× 93 0.6× 229 1.9× 32 949
Hiroyuki Masuno Japan 19 290 0.9× 309 1.0× 219 1.1× 71 0.4× 59 0.5× 37 1.1k
Sonia M. de Morais United States 12 611 1.8× 257 0.9× 25 0.1× 323 1.9× 224 1.9× 17 998
Ai Tamura Japan 18 677 2.0× 402 1.3× 28 0.1× 221 1.3× 74 0.6× 30 1.0k
Frederick H. Hausheer United States 18 998 3.0× 392 1.3× 96 0.5× 116 0.7× 77 0.6× 40 1.5k

Countries citing papers authored by I‐Wu Chen

Since Specialization
Citations

This map shows the geographic impact of I‐Wu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I‐Wu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I‐Wu Chen more than expected).

Fields of papers citing papers by I‐Wu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I‐Wu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I‐Wu Chen. The network helps show where I‐Wu Chen may publish in the future.

Co-authorship network of co-authors of I‐Wu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of I‐Wu Chen. A scholar is included among the top collaborators of I‐Wu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I‐Wu Chen. I‐Wu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tiller, Philip R., et al.. (2008). Metabolite identification of small interfering RNA duplex by high‐resolution accurate mass spectrometry. Rapid Communications in Mass Spectrometry. 22(12). 1871–1881. 62 indexed citations
2.
Wai, John, Bo Young Kim, Thorsten E. Fisher, et al.. (2007). Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(20). 5595–5599. 21 indexed citations
3.
Guare, James P., John Wai, Robert Gomez, et al.. (2006). A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(11). 2900–2904. 37 indexed citations
4.
Bergman, Jeffrey M., Donna Wei, C. Blair Zartman, et al.. (2001). Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 11(4). 537–540. 22 indexed citations
5.
Singh, Rominder, I‐Wu Chen, Lixia Jin, et al.. (2001). Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.. PubMed. 29(12). 1578–87. 7 indexed citations
6.
Lin, Jiunn H., I‐Wu Chen, Masato Chiba, Joy A. Nishime, & F A deLuna. (2000). Route-Dependent Nonlinear Pharmacokinetics of a Novel HIV Protease Inhibitor: Involvement of Enzyme Inactivation. Drug Metabolism and Disposition. 28(4). 460–466. 11 indexed citations
7.
Coburn, Craig A., Peter Williams, Carl F. Homnick, et al.. (2000). Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(10). 1069–1072. 19 indexed citations
8.
Dinsmore, Christopher J., C. Blair Zartman, Walter F. Baginsky, et al.. (2000). Synthesis of Conformationally Constrained 5,6,7,8-Tetrahydroimidazo[1,5-a]pyridine Inhibitors of Farnesyltransferase. Organic Letters. 2(22). 3473–3476. 10 indexed citations
9.
Lin, Jiunn H., Masato Chiba, I‐Wu Chen, et al.. (1999). Effect of Dexamethasone on the Intestinal First-Pass Metabolism of Indinavir in Rats: Evidence of Cytochrome P-450 A and p-Glycoprotein Induction. Drug Metabolism and Disposition. 27(10). 1187–1193. 34 indexed citations
10.
Chiba, Masato, Joy A. Nishime, I‐Wu Chen, et al.. (1998). Metabolite–P450 Complex Formation by Methylenedioxyphenyl HIV Protease Inhibitors in Rat and Human Liver Microsomes. Biochemical Pharmacology. 56(2). 223–230. 8 indexed citations
11.
Sanderson, Philip E.J., Bruce D. Dorsey, Colleen M. McDonough, et al.. (1998). L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor. Bioorganic & Medicinal Chemistry Letters. 8(7). 817–822. 51 indexed citations
12.
Isaacs, Richard C.A., Philip E.J. Sanderson, Elizabeth Baskin, et al.. (1998). C6 Modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption. Bioorganic & Medicinal Chemistry Letters. 8(13). 1719–1724. 19 indexed citations
13.
Feng, Dong-Mei, Stephen J. Gardell, Sidney D. Lewis, et al.. (1997). Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position. Journal of Medicinal Chemistry. 40(23). 3726–3733. 53 indexed citations
14.
Tucker, Thomas J., William C. Lumma, Sidney D. Lewis, et al.. (1997). Potent Noncovalent Thrombin Inhibitors That Utilize the Unique Amino Acid d-Dicyclohexylalanine in the P3 Position. Implications on Oral Bioavailability and Antithrombotic Efficacy. Journal of Medicinal Chemistry. 40(11). 1565–1569. 48 indexed citations
15.
Tucker, Thomas J., William C. Lumma, Sidney D. Lewis, et al.. (1997). Synthesis of a Series of Potent and Orally Bioavailable Thrombin Inhibitors That Utilize 3,3-Disubstituted Propionic Acid Derivatives in the P3 Position. Journal of Medicinal Chemistry. 40(22). 3687–3693. 31 indexed citations
16.
Kwei, Gloria Y., Linda Novak, Lisa Hettrick, et al.. (1995). Regiospecific Intestinal Absorption of the HIV Protease Inhibitor L-735,524 in Beagle Dogs. Pharmaceutical Research. 12(6). 884–888. 23 indexed citations
17.
Lin, Jiunn H., I‐Wu Chen, & F A deLuna. (1994). On the Absorption of Alendronate in Rats. Journal of Pharmaceutical Sciences. 83(12). 1741–1746. 60 indexed citations
18.
Hungate, Randall W., Joseph P. Vacca, Stacey L. McDaniel, et al.. (1994). Synthesis, antiviral activity, and bioavailability studies of γ-lactam derived HIV protease inhibitors. Bioorganic & Medicinal Chemistry. 2(9). 859–879. 16 indexed citations
19.
Vacca, Joseph P., James P. Guare, Stuart R. Michelson, et al.. (1994). A new hydroxyethylamine class of HIV-1 protease inhibitors with high antiviral potency and oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 4(19). 2273–2278. 8 indexed citations
20.
Lin, Jiunn H., I‐Wu Chen, & F A deLuna. (1991). Dose-Dependent Pharmacokinetics of MK-417, a Potent Carbonic Anhydrase Inhibitor, in Experimental Polycythemic and Anemic Rats. Pharmaceutical Research. 8(5). 608–614. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026